Showing results (3781-3790 of 6,795) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|October 2, 2021
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECASTRajaventhan Srirajaskanthan, Marianne Pavel, Matthew Kulke, et al.
Clinical Therapeutics|October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective StudyNaoto Okada, Yuki Izumi, Aki Nakamoto, et al.
Clinical Therapeutics|January 1, 1986
Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infectionsJ S Solomkin, D M Cocchetto
Clinical Therapeutics|January 1, 1986
Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertensionC L Curry, S M Janda, R Harris, et al.
Clinical Therapeutics|April 26, 2022
Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in TaiwanChih-Lang Lin, Yi-Lan Lin, Kung-Hao Liang, et al.
Clinical Therapeutics|January 1, 1986
Comparison of diflunisal and naproxen for relief of anterior knee painJ P Fulkerson, M A Folcik
Clinical Therapeutics|June 15, 2019
Mucosa Biology and the Development of Rheumatoid Arthritis: Potential for Prevention by Targeting Mucosal ProcessesM Kristen Demoruelle
Clinical Therapeutics|June 15, 2019
Potential of Lifestyle Changes for Reducing the Risk of Developing Rheumatoid Arthritis: Is an Ounce of Prevention Worth a Pound of Cure?Alessandra Zaccardelli, H Maura Friedlander, Julia A Ford, et al.
Clinical Therapeutics|June 17, 2019
Comparative Bioavailability Study of a New Orodispersible Formulation of Ibuprofen Versus Two Existing Oral Tablet Formulations in Healthy Male and Female VolunteersDalma Sugár, Danielle Francombe, Tiago da Silva, et al.
Clinical Therapeutics|July 4, 2019
Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy SubjectsWeifeng Tang, Helena Engman, Yali Zhu, et al.
Pageof 680